| First Author | Pizzuto M | Year | 2024 |
| Journal | Cell Rep | Volume | 43 |
| Issue | 10 | Pages | 114788 |
| PubMed ID | 39340778 | Mgi Jnum | J:358149 |
| Mgi Id | MGI:7779412 | Doi | 10.1016/j.celrep.2024.114788 |
| Citation | Pizzuto M, et al. (2024) Ornithine lipid is a partial TLR4 agonist and NLRP3 activator. Cell Rep 43(10):114788 |
| abstractText | Gram-negative bacterial lipopolysaccharides (LPSs) trigger inflammatory reactions through Toll-like receptor 4 (TLR4) and prime myeloid cells for inflammasome activation. In phosphate-limited environments, bacteria reduce LPS and other phospholipid production and synthesize phosphorus-free alternatives such as amino-acid-containing lipids like the ornithine lipid (OL). This adaptive strategy conserves phosphate for other essential cellular processes and enhances bacterial survival in host environments. While OL is implicated in bacterial pathogenicity, the mechanism is unclear. Using primary murine macrophages and human mononuclear cells, we elucidate that OL activates TLR4 and induces potassium efflux-dependent nucleotide-binding domain and leucine-rich repeat-containing pyrin protein 3 (NLRP3) activation. OL upregulates the expression of NLRP3 and pro-interleukin (IL)-1beta and induces cytokine secretion in primed and unprimed cells. By contrast, in the presence of LPS, OL functions as a partial TLR4 antagonist and reduces LPS-induced cytokine secretion. We thus suggest that in phosphate-depleted environments, OL replaces LPS bacterial immunogenicity, while constitutively present OL may allow bacteria to escape immune surveillance. |
